Join Medicilon at the AAPS 2021 PharmSci 360

2021-10-12

Page View：

Join Medicilon at the AAPS 2021 PharmSci 360

Medicilon is looking forward to meeting you at this year’s American Association of Pharmaceutical Scientists (AAPS) annual meeting—“PharmSci 360″.

PharmSci 360 is an in-person meeting + virtual that include:

An expanded match-making service so that you can find the right attendees and book key meetings, making your presence at PharmSci 360 a relationship-building opportunity.
Expanded options for participating in the education and scientific program at PharmSci 360, so that you can present your company as a thought leader.

The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in industry, academia, government, and other pharmaceutical science related research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

This year’s tracks include:

• DISCOVERY & BASIC RESEARCH
• PRECLINICAL DEVELOPMENT
• BIOANALYTICS
• PHARMACOLOGY
• MANUFACTURING & ANALYTICAL CHARACTERIZATION
• FORMULATION & DELIVERY

Since its founding in 2004, Medicilon has grown into a nationally leading preclinical CRO that provides fully integrated preclinical pharmaceutical R&D services. We occupy over 738,000 sqft of lab space, with a full range of advanced lab equipment and a strong research team of more than 2,000 scientists and support staff. Medicilon is committed to helping clients find innovative solutions for pharmaceutical R&D, from target identification toIND filing for clinical trials. Our comprehensive service technology platform integrates compound synthesis, compound activity screening, structural biology,CMC, pharmacodynamics evaluation, pharmacokinetics and toxicological safety evaluation.

Medicilon is fully accredited by AAALAC. Our laboratory standards are certified by FDA, EMEA, TGA and the NMPA for GLP compliance. Over the years, Medicilon has established preclinical research collaborations with over 1,100 clients worldwide.

Drug Discovery
Have established a strong track record assisting thousands of sponsors worldwide with the discovery and development of small molecules, biologics as well as cell- and gene-therapies. Combining the most cutting-edge instrumentation and high-performance, experienced scientists, Medicilon has the expertise, capabilities and capacity to support projects of any size.
Pharmaceutical Research
A wide-range of API services for both innovative and generic drugs including process development and optimization,quality studies, scale-up, technology transfer, process validation, and IND registration service. Extensive experience in supporting a wide variety of formulation dosage forms including capsules, tablets, granules, injections, inhalants lyophilized powders, eye drops, ointments, tinctures, etc.
Preclinical Research
Includes toxicology, pharmacology and efficacy studies, ADME, DMPK, as well as bioanalytical solutions for small molecules, biologics, and medicinal herbs. We maintain a large in-house library of animal disease models to meet the research demands in different therapeutic areas. Medicilon can also assist sponsors in the preparation of a preclinical safety evaluation package.